Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Feb 5:10:57.
doi: 10.3389/fphar.2019.00057. eCollection 2019.

The Regulatory Effects of Paeoniflorin and Its Derivative Paeoniflorin-6'-O-Benzene Sulfonate CP-25 on Inflammation and Immune Diseases

Jiajie Tu  1 , Yawei Guo  1 , Wenming Hong  1   2 , Yilong Fang  1 , Dafei Han  1 , Pengying Zhang  1 , Xinming Wang  1 , Heinrich Körner  1 , Wei Wei  1
Affiliations
Review

The Regulatory Effects of Paeoniflorin and Its Derivative Paeoniflorin-6'-O-Benzene Sulfonate CP-25 on Inflammation and Immune Diseases

Jiajie Tu et al. Front Pharmacol. .

Abstract

The plant extract "total glucosides of peony" (TGP) constitutes a mixture of glycosides that is isolated from the roots of the well-known traditional Chinese herb Paeonia lactiflora Pall. Paeoniflorin (Pae) is the most abundant component and the main biologically active ingredient of TGP. Pharmacologically, Pae exhibits powerful anti-inflammatory and immune regulatory effects in some animal models of autoimmune diseases including Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE). Recently, we modified Pae with an addition of benzene sulfonate to achieve better bioavailability and higher anti-inflammatory immune regulatory effects. This review summarizes the pharmacological activities of Pae and the novel anti-inflammatory and immunomodulatory agent Paeoniflorin-6'-O-benzenesulfonate (CP-25) in various chronic inflammatory and autoimmune disorders. The regulatory effects of Pae and CP-25 make them promising agents for other related diseases, which require extensive investigation in the future.

Keywords: CP-25; Pae; arthritis; inflammation; treatment.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
The developmental process of TGP-Pae-CP-25.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Absolute T. H. E., Of S., Chinese F., Root P. (1972). Chemical studies on the oriental plant drugs—XXXIII: the absolute structures of paeoniflorin, albiflorin, oxypaeoniflorin and benzoylpaeoniflorin isolated from chinese paeony root. Tetrahedron 28 4309–4317.
    1. Aoki T., Narumiya S. (2017). Prostaglandin E2-EP2 signaling as a node of chronic inflammation in the colon tumor microenvironment. Inflamm. Regen. 37:4. 10.1186/s41232-017-0036-7 - DOI - PMC - PubMed
    1. Chan K., Liu Z. Q., Jiang Z. H., Zhou H., Wong Y. F., Xu H. X., et al. (2006). The effects of sinomenine on intestinal absorption of paeoniflorin by the everted rat gut sac model. J. Ethnopharmacol. 103 425–432. 10.1016/j.jep.2005.08.020 - DOI - PubMed
    1. Chang Y., Jia X., Wei F., Wang C., Sun X., Xu S., et al. (2016). CP-25, a novel compound, protects against autoimmune arthritis by modulating immune mediators of inflammation and bone damage. Sci. Rep. 6:262394. 10.1038/srep26239 - DOI - PMC - PubMed
    1. Chang Y., Zhang L., Wang C., Jia X. Y., Wei W. (2011). Paeoniflorin inhibits function of synoviocytes pretreated by rIL-1α and regulates EP4receptor expression. J. Ethnopharmacol. 137 1275–1282. 10.1016/j.jep.2011.07.057 - DOI - PubMed